Pernille Ravn

Prevention of Bone Loss with Alendronate in Postmenopausal Women under 60 Years of Age

David Hosking, Clair E.D. Chilvers, Claus Christiansen et al. · New England Journal of Medicine · 1998 · 487 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Low Body Mass Index Is an Important Risk Factor for Low Bone Mass and Increased Bone Loss in Early Postmenopausal Women

Pernille Ravn, Giovanni Cizza, N. H. Bjarnason et al. · Journal of Bone and Mineral Research · 1999 · 455 citations

Medicine, Endocrinology, Bone Metabolism +16

Prevention of Bone Loss With Alendronate in Postmenopausal Women Under 60 Years of Age

David Hosking, Clair Chilvers, Claus Christiansen et al. · Obstetrical & Gynecological Survey · 1998 · 211 citations

Medicine, Endocrinology, Pharmacotherapy +17

Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study

Yu Z. Bagger, László B. Tankó, Peter Alexandersen et al. · Bone · 2004 · 187 citations

Medicine, Endocrinology, Preventive Medicine +15

Alendronate and Estrogen–Progestin in the Long-Term Prevention of Bone Loss: Four-Year Results from the Early Postmenopausal Intervention Cohort Study: A Randomized, Controlled Trial

Pernille Ravn, Marianne Bidstrup, Richard D. Wasnich et al. · Annals of Internal Medicine · 1999 · 187 citations

Medicine, Endocrinology, Pharmacotherapy +17